DK1650191T3 - Terapeutisk middel til kronisk obstruktiv pulmonær sygdom og fremgangsmåde til behandling af kronisk obstruktiv pulmonær sygdom med dette middel - Google Patents

Terapeutisk middel til kronisk obstruktiv pulmonær sygdom og fremgangsmåde til behandling af kronisk obstruktiv pulmonær sygdom med dette middel

Info

Publication number
DK1650191T3
DK1650191T3 DK04771118.9T DK04771118T DK1650191T3 DK 1650191 T3 DK1650191 T3 DK 1650191T3 DK 04771118 T DK04771118 T DK 04771118T DK 1650191 T3 DK1650191 T3 DK 1650191T3
Authority
DK
Denmark
Prior art keywords
pulmonary disease
chronic obstructive
obstructive pulmonary
group
agent
Prior art date
Application number
DK04771118.9T
Other languages
English (en)
Inventor
Hidetsugu Takagaki
Yasuo Aoki
Mitsuteru Ishiwara
Nobuaki Mizutani
Original Assignee
Mariposa Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mariposa Health Ltd filed Critical Mariposa Health Ltd
Application granted granted Critical
Publication of DK1650191T3 publication Critical patent/DK1650191T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK04771118.9T 2003-07-30 2004-07-27 Terapeutisk middel til kronisk obstruktiv pulmonær sygdom og fremgangsmåde til behandling af kronisk obstruktiv pulmonær sygdom med dette middel DK1650191T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003203699 2003-07-30
PCT/JP2004/011013 WO2005012251A1 (ja) 2003-07-30 2004-07-27 慢性閉塞性肺疾患治療剤及びそれを用いた慢性閉塞性肺疾患の治療方法

Publications (1)

Publication Number Publication Date
DK1650191T3 true DK1650191T3 (da) 2012-05-07

Family

ID=34113624

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04771118.9T DK1650191T3 (da) 2003-07-30 2004-07-27 Terapeutisk middel til kronisk obstruktiv pulmonær sygdom og fremgangsmåde til behandling af kronisk obstruktiv pulmonær sygdom med dette middel

Country Status (11)

Country Link
US (2) US8980914B2 (da)
EP (1) EP1650191B1 (da)
KR (1) KR101100659B1 (da)
CN (1) CN100422155C (da)
AT (1) ATE553087T1 (da)
AU (1) AU2004261527B2 (da)
CA (1) CA2533919C (da)
DK (1) DK1650191T3 (da)
ES (1) ES2382937T3 (da)
TW (1) TWI344365B (da)
WO (1) WO2005012251A1 (da)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2943725B2 (ja) * 1996-01-17 1999-08-30 大日本インキ化学工業株式会社 キノリノン誘導体及びそれを有効成分とする抗アレルギー剤
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
TW430656B (en) * 1997-12-03 2001-04-21 Dainippon Ink & Chemicals Quinolinone derivative, method for preparing the same, and anti-allergic agent
KR100908418B1 (ko) * 2001-06-20 2009-07-21 액티버스 파마 컴퍼니 리미티드 퀴놀리논 유도체 의약 조성물 및 그의 제조 방법

Also Published As

Publication number Publication date
KR101100659B1 (ko) 2012-01-03
CA2533919C (en) 2010-10-12
AU2004261527A1 (en) 2005-02-10
ES2382937T3 (es) 2012-06-14
EP1650191A1 (en) 2006-04-26
US20060235045A1 (en) 2006-10-19
EP1650191A4 (en) 2008-08-20
EP1650191B1 (en) 2012-04-11
WO2005012251A1 (ja) 2005-02-10
TWI344365B (en) 2011-07-01
US20150157621A1 (en) 2015-06-11
CN100422155C (zh) 2008-10-01
TW200509927A (en) 2005-03-16
CA2533919A1 (en) 2005-02-10
US8980914B2 (en) 2015-03-17
AU2004261527B2 (en) 2010-09-23
CN1829693A (zh) 2006-09-06
KR20060041286A (ko) 2006-05-11
ATE553087T1 (de) 2012-04-15

Similar Documents

Publication Publication Date Title
NO20023997D0 (no) 2-okso-1-pyrrolidinderivater, fremgangsmåter for deres fremstilling, og deres anvendelse
NO20021328L (no) Pyrazolopyrimidier som terapeutiske midler
NO20020968D0 (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
CY1106679T1 (el) Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
CY1106674T1 (el) Αζαδικυκλικοι ετεροκυκλοι σαν ρυθμιστες υποδοχεα κανναβινοειδους
NO20042811L (no) Substituerte henzoksazoler og analoger som estrogene midler
NO20073357L (no) 5-karboksamid substituerte tiazol derivater som reagerer med ionekanaler, i saerdeleshet med ionekanaler fra Kv familien
NO20051527D0 (no) 3-(sulfonamidoetyl) -indol-derivater for anvendelse som glukocorticoid-mimetica ved behandling av inflammatoriske, allergiske og proliferative sykdommer.
NO20051209L (no) Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk anvendelse derav samt intermediater for samme
NO20064282L (no) Morfolinforbindelser
ATE503746T1 (de) Neue imidazolidinderivate
ECSP045483A (es) Derivados de heteroarilamida benzocondensada de tienopiridinas útiles como agentes terapéuticos, composiciones farmacéuticas que incluyen a los mismos, y métodos para su uso
NO20065327L (no) Fremgangsmate for fremstilling av derivarer av 5-'4-(2-hydroksy-propyl)-3,5-dihydro-3H'1, 2,4(triazin-2-yl)-benzamid.
ATE397605T1 (de) Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol
NO20062491L (no) Benzoksazinderivter og deres anvendelse
NO20063576L (no) 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes
HK1107814A1 (en) Thiadiazoline derivatives for treating cancer
NO20052908D0 (no) Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
MXPA05011176A (es) Derivados de carboxamida como agentes antidiabeticos.
UY27685A1 (es) Indolil-urea derivados de tienopiridinas útiles como agentes antiangiogénicos, y procedimientos para su uso
DK0682947T3 (da) Medikament til terapeutisk og profylaktisk behandling af sygdomme forårsaget af glatmuskelcelle-hyperplasi
NO20080669L (no) Acetylenpiperaziner som metabotrofiske glutamatreseptorantagonister
DK1650191T3 (da) Terapeutisk middel til kronisk obstruktiv pulmonær sygdom og fremgangsmåde til behandling af kronisk obstruktiv pulmonær sygdom med dette middel
NO20070421L (no) Radiosensitiviserende middel